Abbott Labs (GB:0Q15)

Abbott Labs (0Q15) Financial Statements


Abbott Labs Financial Overview

Abbott Labs's market cap is currently ―. The company's EPS TTM is $3.289; its P/E ratio is 31.57; and it has a dividend yield of 1.91%. Abbott Labs is scheduled to report earnings on July 19, 2023, and the estimated EPS forecast is $1.05. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 9.75B$ 10.09B$ 10.41B$ 11.26B$ 11.89B
Gross Profit$ 5.42B$ 5.50B$ 5.78B$ 6.32B$ 6.91B
EBIT$ 1.61B$ 1.47B$ 1.90B$ 2.48B$ 3.01B
EBITDA$ 2.10B$ 2.28B$ 2.71B$ 3.31B$ 3.83B
Net Income Common Stockholders$ 1.32B$ 1.03B$ 1.44B$ 2.02B$ 2.45B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.53B$ 10.17B$ 9.91B$ 9.29B$ 8.16B
Total Assets$ 73.77B$ 74.44B$ 72.80B$ 74.20B$ 74.01B
Total Debt$ 16.90B$ 17.72B$ 16.41B$ 16.76B$ 17.09B
Net Debt$ 7.37B$ 7.55B$ 6.51B$ 7.47B$ 8.93B
Total Liabilities$ 36.56B$ 37.53B$ 36.92B$ 37.49B$ 38.38B
Stockholders Equity$ 37.01B$ 36.69B$ 35.67B$ 36.49B$ 35.40B
Cash Flow-
Free Cash Flow$ 763.00M$ 1.72B$ 2.31B$ 2.03B$ 1.74B
Operating Cash Flow$ 1.14B$ 2.33B$ 2.78B$ 2.41B$ 2.06B
Investing Cash Flow$ -462.00M$ -632.00M$ -484.00M$ -264.00M$ -360.00M
Financing Cash Flow$ -1.41B$ -1.46B$ -1.54B$ -813.00M$ -3.82B
Currency in USD

Abbott Labs Earnings and Revenue History

Abbott Labs Debt to Assets

Abbott Labs Cash Flow

Abbott Labs Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis